1. Academic Validation
  2. Hierarchically collapsible nanoactuator modulates mitochondrial ferroptosis-bioenergetic homeostasis cascade to decouple ischemic stroke

Hierarchically collapsible nanoactuator modulates mitochondrial ferroptosis-bioenergetic homeostasis cascade to decouple ischemic stroke

  • Cell Rep Med. 2026 Mar 17;7(3):102640. doi: 10.1016/j.xcrm.2026.102640.
Guangjie Sun 1 Yize Dong 1 Ying Wang 2 Yihong Su 1 Jiajun Chen 1 Jiali Deng 1 Lan Luo 1 Xinyue Cao 2 Weiping Lu 2 Kai Chen 2 Meihua Yu 3 Yujie Xie 4 Bingcang Huang 5 Yu Chen 6
Affiliations

Affiliations

  • 1 Department of Radiology, Gongli Hospital of Shanghai Pudong New Area, Shanghai 200135, China; School of Gongli Hospital Medical Technology, University of Shanghai for Science and Technology, Shanghai 200093, China.
  • 2 Department of Radiology, Gongli Hospital of Shanghai Pudong New Area, Shanghai 200135, China.
  • 3 Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, China. Electronic address: [email protected].
  • 4 School of Medicine, Shanghai University, Shanghai 200444, China. Electronic address: [email protected].
  • 5 Department of Radiology, Gongli Hospital of Shanghai Pudong New Area, Shanghai 200135, China. Electronic address: [email protected].
  • 6 Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai 200444, China; School of Medicine, Shanghai University, Shanghai 200444, China; Shanghai Institute of Materdicine, Shanghai 200052, China. Electronic address: [email protected].
Abstract

Ischemic stroke, a life-altering cerebrovascular emergency triggered by prolonged cerebral hypoperfusion, remains a therapeutic enigma. Current interventions struggle with ischemia-reperfusion injury; restoring blood flow unleashes Reactive Oxygen Species (ROS), driving secondary neuronal damage and functional loss. Ischemia-induced mitochondrial dysfunction heightens oxidative stress and hastens neuronal death. We address oxidative-stress-driven neuronal injury by engineering a hierarchically collapsible nanoactuator suppressing mitochondrial Ferroptosis and restoring cellular energy homeostasis. The nanoactuator integrates a diselenide-crosslinked shell conjugated with a mitochondrial-targeting peptide, enabling blood-brain barrier penetration and mitochondrial delivery. Its collapsible core, composed of an ATP-gadolinium coordination polymer encapsulating a Ferroptosis inhibitor, enables MRI-guided tracking and ROS-responsive drug release. In damaged mitochondria, the nanoactuator replenishes ATP, restores membrane potential, reduces ROS levels, and alleviates Ferroptosis. Intravenous administration in a transient middle cerebral artery occlusion (tMCAO) mouse model demonstrated robust multi-mechanistic neuroprotection. This hierarchical nanoactuator platform offers a strategy for ischemic stroke and related neurodegenerative diseases.

Keywords

energetic homeostasis; ferroptosis; ischemia-reperfusion injury; ischemic stroke; nanoactuator; oxidative stress.

Figures
Products
Inhibitors & Agonists
Other Products